◆ 会议时间：2026年4月29日-5月2日
◆ 会议地点：美国 明尼阿波利斯
◆ 会议简介：
2026年美国儿科血液学肿瘤学会(ASPHO)年会将于2026年4月29日-5月2日在美国明尼阿波利斯举行。ASPHO年会是儿科血液学肿瘤学领域首屈一指的学术会议，不仅为与会者提供高质量的教育内容，同时也是与同行建立联系，分享交流该领域创新进展的平台。预计有来自世界各地的1200余名专业人士与会。
美国儿科血液学肿瘤学会(ASPHO)成立于1981年，现拥有2000余名会员，ASPHO是唯一致力于宣促进儿科血液学/肿瘤学专科医生专业发展和兴趣的专业组织。ASPHO是一个多学科组织，通过推进研究、教育、治疗和专业实践，对患有血液疾病和癌症的儿童和青少年提供最佳的护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。
ASPHO 2026 - American Society of Pediatric Hematology/Oncology Conference
Date:
April 29 - May 2, 2026
Venue:
Minneapolis, MN, USA
More than 1,200 pediatric hematology/oncology professionals from around the world attend the ASPHO Conference. A flagship meeting for the field, the ASPHO Conference allows attendees to receive high-quality educational content, network with their colleagues, and discover innovative advancements in pediatric hematology/oncology.
Attendees receive superior educational programming from internationally known experts in the field of pediatric hematology/oncology. The educational programming includes a dynamic variety of symposia, workshops, plenary sessions, and poster sessions.
重要日期：
2026 Call for Workshops
May 7 - July 31, 2025
2026 Call for Abstracts
October 2 - December 18, 2025
2026 Call for Late-Breaking Abstracts
January 5 - January 29, 2026
The abstract submitter will receive notification of the committee’s decision by March 16, 2026.
点此提交摘要>>>Submit Abstract>>>
Fee
There will be a $30.00 USD (ASPHO Member) or a $45.00 USD (non-member) non-refundable fee per abstract to be paid by credit card through PayPal. The fee will be collected at the end of the submission process, before the abstract can be submitted. Payment must be done online within the system during the time of submission (payment will not be taken in any other form such as by phone or check). NOTE: Your submission will not be considered 'complete' until the payment is processed and the proposal is submitted, so please take this step into consideration when you submit your proposal.
General Information
- All communication will go to the Submitter.
- Abstracts are limited to 400 words, including any references listed. In addition, up to one figure, graph, or table (limit one) may be uploaded as an attachment as part of the abstract submission.
- All submitters (including those who submit case reports/series) must include the following components in the body of the abstract:
- Background
- Objective
- Design/Method
- Results
- Conclusion
- Submitters must indicate the institution, city, state, and country where the research was done.
- All abstracts (including case reports/case series) must be identified by a theme/topic. This information is used for the appropriate grouping of papers and posters at the conference as well as for publication in the Pediatric Blood & Cancer Journal and on the ASPHO website.
If you are submitting a case report/series, please select accordingly
Please note: It is up to the discretion of the ASPHO Conference Planning Committee to make the final assignment regarding the abstract’s theme.
- Hemostasis, Thrombosis, and Vascular Biology
- Red Cells
- General Hematology
- Leukemia/Lymphoma/Histiocyte Disorders
- Solid Tumors
- General Oncology
- Hematopoietic Stem Cell Transplantation and Cellular Therapy
- Outcomes Research
- Outcomes Research is research that describes the end result of health care practices and intervention. Examples include studies related to cost effectiveness, health status, disease burden, late effects of treatments, and quality of life.
- Quality Improvement/Patient Safety
- Quality improvement abstracts are based on improvement of health and health care. The abstracts can be related to patient safety, processes to improve outcomes such as time to antibiotics and influenza initiatives, but the abstracts need to be based on clear evidence. Mention of key terms such as Global and Smart aims, Key Drivers, and PDSA ramps need to be included as well.
- Mark whether your abstract is a case report/case series (a case report/case series is defined as a study that includes 5 or less subjects)
- All case reports must include at least some data, otherwise, the abstract will be rejected.
- Submitters should also indicate:
- If you must cite a reference, please do so at the end of the abstract using the following format: author name, publication name, and year of publication (e.g., Smith, Ped Blood & Cancer, 2023).
- All accepted abstracts will be published on the ASPHO website and in the Pediatric Blood & Cancer Journal (online format) as submitted.
Please check your submission carefully before clicking the "Submit" button in the submission system.
ASPHO will not allow any changes to the abstract once the system closes on December 18, 2025.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
